IRCT20121021011192N7 IRCT 2019-01-10 Shahid Beheshti University of Medical Sciences buccal buspirone in GERD patients empty comparison of the effect of buccal buspirone administration with placebo in improvement of clinical symptoms in GERD patients 2018-10-22 anticipated 58 Complete https://irct.ir/trial/35486 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple individual randomization with Microsoft Excel software, Blinding description: Participants, principle investigator, healthcare providers (Physicians, nurses) who care for participants during the trial, data collectors and outcome assessors all are blinded by providing placebo buccal buspirone in same size, shape color, odor and package with real buccal buspirone which organized just by one responsible co-researcher has no involvement in running study. 3 GERD. Intervention 1: Intervention group: Addition of buspirone buccal tablet 10 mg/d to omeprazol capsule 20 mg/ d for treatment of GERD for 1 month. Intervention 2: Control group: Addition of buspirone placebo buccal tablet 10 mg/d to omeprazol capsule 20 mg/ d for treatment of GERD for 1 month. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information.